References
- Ruiz-Argüelles GJ, Ruiz-Delgado GJ, Garcés-Eisele J, et al. Donor cell leukemia after non-myeloablative allogeneic stem cell transplantation: a single institution experience. Leuk Lymphoma. 2006;47:1952–1955.
- Ruiz-Argüelles GJ, Ruiz-Argüelles A, Garcés-Eisele J. Donor cell leukemia: a critical review. Leuk Lymphoma. 2007;48:25–38.
- Ruiz-Delgado GJ, Hernández-Reyes J, González-Ramírez MP, et al. Leucemia en células del donador: un estudio prospectivo de su identificación y tratamiento. Gac Méd Méx. 2015;151:582–587.
- Kim YI, Kim HR, Shin MG, et al. Donor cell origin of multiple myeloma occurring after allogeneic stem cell transplantation in a patient with refractory anemia with ring sideroblast. J Clin Pathol. 2011;64:265–268.
- Fahkri B, Fiala M, Slade M, et al. Donor-derived smoldering multiple myeloma following a hematopoietic cell transplantation for AML. Case Rep Hematol. 2017;2017:3728429. article ID 3728429.
- Peri N, Kussick S, Bakthavatsalam R, et al. Postrenal transplant non-EBV multiple myeloma of donor origin. Am J Transplant. 2006;6:419–422.
- Yousem SA, Randhawa P, Locker J, et al. Posttransplant lymphoproliferative disorders in heart-lung transplant recipients: primary presentation in the allograft. Hum Pathol. 1989;20:361–369.
- Kumar A, Styler MJ, Topolsky DL, et al. Occurrence of multiple myeloma in both donor and recipient after bone marrow transplantation. Am J Hematol. 2002;71:227–228.
- Maestas E, Jain S, Stiff P. A 54-year-old woman with donor cell origin of multiple myeloma after allogeneic hematopoietic stem cell transplantation for the treatment of CML. Case Rep Hematol. 2016;2016:6751914.
- Ruiz-Argüelles GJ, Reyes-Núñez V, Garcés-Eisele J, et al. Acquired hemoglobin S trait in an adult patient with secondary acute myelogenous leukemia allografted with matched unrelated umbilical cord blood cells using a non-ablative conditioning regimen. Haema. 2005;8:492–496.
- Ruiz-Argüelles GJ, Gómez-Almaguer D, Ruiz-Argüelles A, et al. Results of an outpatient-based stem cell allotransplant program using non-myeloablative conditioning regimens. Am J Hematol. 2001;66:241–244.
- Lawler M, Mc Cann SR. Polymerase chain reaction based methods for assessing chimerism following bone marrow transplantation. In: Cotter FE, editors. Molecular diagnosis of cancer. Totowa (NJ): Humana Press Inc; 1996. p. 105–120.
- Odriozola A, Riancho JA, Colorado M, et al. Evaluation of the sensitivity of two recently developed STR multiplexes for the analysis of chimerism after haematopoietic stem cell transplantation. Int J Immunogenet. 2013;40:88–92.
- Saiki RK, Scharf S, Faloona F, et al. Enzymatic amplification of beta-globin genomic sequences and restriction site analysis for diagnosis of sickle cell anemia. Science. 1985;230:1350–1354.
- Greening DW, Gopal SK, Xu R, et al. Exosomes and their roles in immune regulation and cancer. Semin Cell Dev Biol. 2015;40:72–81.